tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Ratios

Compare
2,977 Followers

ADMA Biologics Ratios

ADMA's free cash flow for Q3 2025 was $0.56. For the 2025 fiscal year, ADMA's free cash flow was decreased by $ and operating cash flow was $0.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.13 5.97 5.16 6.89 6.87
Quick Ratio
3.65 2.90 1.69 2.73 2.77
Cash Ratio
1.09 1.86 1.03 2.20 1.68
Solvency Ratio
1.58 1.47 -0.10 -0.40 -0.58
Operating Cash Flow Ratio
1.15 2.14 0.18 -1.52 -3.70
Short-Term Operating Cash Flow Coverage
17.84 0.00 -48.35 0.00 0.00
Net Current Asset Value
$ 265.15M$ 191.75M$ 63.04M$ 73.91M$ 73.65M
Leverage Ratios
Debt-to-Assets Ratio
0.15 0.17 0.43 0.44 0.37
Debt-to-Equity Ratio
0.19 0.24 1.05 1.02 0.73
Debt-to-Capital Ratio
0.16 0.19 0.51 0.50 0.42
Long-Term Debt-to-Capital Ratio
0.14 0.17 0.49 0.48 0.40
Financial Leverage Ratio
1.32 1.40 2.43 2.29 1.96
Debt Service Coverage Ratio
18.81 15.77 0.21 -3.06 -5.07
Interest Coverage Ratio
19.97 9.98 0.86 -2.04 -4.47
Debt to Market Cap
0.02 0.02 0.13 0.19 0.48
Interest Debt Per Share
0.38 0.41 0.74 0.88 0.83
Net Debt to EBITDA
0.13 -0.14 17.59 -1.71 -0.97
Profitability Margins
Gross Profit Margin
54.71%51.48%34.44%22.89%1.45%
EBIT Margin
33.60%32.75%-1.24%-30.26%-72.39%
EBITDA Margin
35.23%34.63%1.98%-25.78%-65.89%
Operating Profit Margin
34.19%32.59%8.38%-25.55%-72.12%
Pretax Profit Margin
31.88%29.48%-10.94%-42.77%-88.52%
Net Profit Margin
42.87%46.35%-10.94%-55.29%-104.34%
Continuous Operations Profit Margin
42.87%46.35%-10.94%-42.77%-88.52%
Net Income Per EBT
134.45%157.24%100.00%129.25%117.87%
EBT Per EBIT
93.27%90.45%-130.54%167.42%122.74%
Return on Assets (ROA)
36.83%40.45%-8.58%-24.45%-30.57%
Return on Equity (ROE)
53.98%56.64%-20.89%-56.05%-59.82%
Return on Capital Employed (ROCE)
32.61%32.09%7.74%-12.73%-23.74%
Return on Invested Capital (ROIC)
32.38%32.00%7.72%-16.41%-27.92%
Return on Tangible Assets
37.09%40.78%-8.68%-24.77%-31.16%
Earnings Yield
5.07%4.95%-2.79%-11.10%-42.91%
Efficiency Ratios
Receivables Turnover
3.55 8.53 9.42 9.94 2.83
Payables Turnover
9.21 10.23 10.81 8.98 6.42
Inventory Turnover
1.13 1.22 0.98 0.73 0.64
Fixed Asset Turnover
6.20 6.73 4.07 2.24 1.39
Asset Turnover
0.86 0.87 0.78 0.44 0.29
Working Capital Turnover Ratio
1.46 1.77 1.18 0.75 0.52
Cash Conversion Cycle
387.64 307.44 377.83 497.69 642.69
Days of Sales Outstanding
102.85 42.79 38.76 36.73 128.86
Days of Inventory Outstanding
324.41 300.32 372.83 501.60 570.70
Days of Payables Outstanding
39.62 35.67 33.77 40.64 56.87
Operating Cycle
427.26 343.11 411.59 538.33 699.56
Cash Flow Ratios
Operating Cash Flow Per Share
0.27 0.51 0.04 -0.30 -0.81
Free Cash Flow Per Share
0.17 0.47 0.02 -0.37 -0.90
CapEx Per Share
0.10 0.04 0.02 0.07 0.10
Free Cash Flow to Operating Cash Flow
0.63 0.93 0.43 1.23 1.12
Dividend Paid and CapEx Coverage Ratio
2.68 13.84 1.77 -4.28 -8.32
Capital Expenditure Coverage Ratio
2.68 13.84 1.77 -4.28 -8.32
Operating Cash Flow Coverage Ratio
0.78 1.45 0.06 -0.39 -1.09
Operating Cash Flow to Sales Ratio
0.13 0.28 0.03 -0.39 -1.39
Free Cash Flow Yield
0.99%2.75%0.38%-9.56%-63.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.71 20.22 -35.85 -9.01 -2.33
Price-to-Sales (P/S) Ratio
8.43 9.37 3.92 4.98 2.43
Price-to-Book (P/B) Ratio
9.57 11.45 7.49 5.05 1.39
Price-to-Free Cash Flow (P/FCF) Ratio
101.10 36.31 265.09 -10.46 -1.56
Price-to-Operating Cash Flow Ratio
63.53 33.68 115.04 -12.90 -1.75
Price-to-Earnings Growth (PEG) Ratio
0.20 -0.03 0.51 0.31 0.06
Price-to-Fair Value
9.57 11.45 7.49 5.05 1.39
Enterprise Value Multiple
24.05 26.92 215.32 -21.04 -4.66
Enterprise Value
4.14B 3.98B 1.10B 835.68M 248.64M
EV to EBITDA
24.05 26.92 215.32 -21.04 -4.66
EV to Sales
8.47 9.32 4.27 5.42 3.07
EV to Free Cash Flow
101.64 36.12 288.67 -11.38 -1.98
EV to Operating Cash Flow
63.70 33.51 125.28 -14.04 -2.21
Tangible Book Value Per Share
1.79 1.48 0.59 0.75 0.97
Shareholders’ Equity Per Share
1.81 1.50 0.60 0.77 1.01
Tax and Other Ratios
Effective Tax Rate
-0.34 -0.57 0.00 -0.29 -0.18
Revenue Per Share
2.05 1.83 1.15 0.78 0.58
Net Income Per Share
0.88 0.85 -0.13 -0.43 -0.61
Tax Burden
1.34 1.57 1.00 1.29 1.18
Interest Burden
0.95 0.90 8.79 1.41 1.22
Research & Development to Revenue
<0.01 <0.01 0.01 0.02 0.05
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.04 0.03 0.02 0.03 0.04
Income Quality
0.31 0.60 -0.31 0.90 1.57
Currency in USD